Market entry decisions often rely on narrow benchmarks, not because deeper analysis isn’t valuable, but because it’s too slow. Finding comparable launches can mean weeks of manual review across historical data. When decades of launch history, pipeline signals and forecasts are brought together, that work shifts from access to interpretation. This development changes not just how fast teams move, but how well they decide. In this Pharmaceutical Executive article, Kapil Chaddha and Dr Abhishek Jaiswal explore how teams are starting to ask—and answer—more complex questions within the decision window. Read the article: https://lnkd.in/ezZ9F3VD
IQVIA Commercial Solutions
Hospitals and Health Care
Smarter decisions. Stronger engagement. Better outcomes.
About us
IQVIA Commercial Solutions empowers biopharma organizations to commercialize treatments with confidence. Key support areas include: • Launch and brand strategy • Market access and medical affairs • HCP engagement • Patient engagement • Commercial data and analytics • Established brands optimization. Our approach is backed by our unparalleled data, deep domain expertise, and advanced analytics & AI. By integrating these strengths, we help clients create agile, data-driven strategies that improve engagement and deliver better outcomes for patients worldwide.
- Website
-
https://www.iqvia.com/solutions/commercialization
External link for IQVIA Commercial Solutions
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Specialties
- Commercialization, Data Management , HCP Reference Data, Sales Data, Market Assessment, Promotional Engagement, Performance Management, HCP Engagement, Patient Engagement, Customer Engagement, Commercial Analytics, Consulting, Pharma Marketing, Launch , Managed Services, Primary Intelligence, Commercial Compliance, Commercial Solutions, Life Sciences, and Commercial Pharma
Updates
-
How do you turn market insights into faster action? Aurelio Arias, explores how agentic AI and advanced analytics are helping teams make more agile, confident decisions across the product lifecycle. Read his latest piece at Reuters: https://lnkd.in/eHTTqbww
-
-
Turn complex commercial data into decisions you can act on—faster. IQVIA Orchestrated Analytics brings data, AI, and analytics together in a single, connected platform, helping commercial teams move with confidence, optimize performance, and respond to change in real time. Ready to see it in action? Let's talk: https://lnkd.in/etw54_Tw
-
Established brands are the overlooked majority in pharma portfolios. Learn how innovative approaches can maximize their potential and deliver sustainable growth. https://lnkd.in/eE3z5NhW
-
Are your launch investments aligned to today's market realities, or yesterday's playbook? Discover how tailored, evidence-based approaches can drive better launch performance, shape emerging therapy areas, and strengthen portfolio planning in complex, competitive markets. Read our white paper: https://lnkd.in/eHShXAdy
-
By combining disease education, injection training, personalized action plans and real‑time nursing support, IQVIA helped a biopharma company achieve 95% compliance in a rare pediatric condition—and expanded the patient support program from 2 to 8 countries. A proven model for scaling digital PSPs with measurable impact. https://lnkd.in/ebMVJXVb
-
We're looking forward to #ASCO26 in Chicago. Stop by booth 36069 to meet our team and discuss how we support oncology development programs. Book time with us here: https://lnkd.in/eMUXrgZQ
-
-
In an AI‑driven age, the role of the MSL has never been more critical. In this article, IQVIA experts Carrie Evans FCIM and Glyn Sheriston share how MSLs continue to bridge clinical development and commercialization, bringing scientific depth, real‑time insight, and trusted relationships across the lifecycle. Read more: https://lnkd.in/eyWyAUAb
-
In a volatile pharma market with increasingly tough launches, established brands are an important revenue stream. The right analytics—paired with local market expertise and resources will help you to redirect investment. Learn more: https://lnkd.in/eh8p6Kh3
-
-
Most commercial teams aren’t short on data — they’re short on confidence in how to use it. When data is fragmented across markets, brands, and functions, it becomes harder to trust insights, connect signals, and act with consistency at scale. IQVIA's point of view is simple: commercial analytics only delivers value when data, integration and workflows are designed together, not in isolation. This thinking underpins IQVIA’s approach to commercial data & analytics—an end‑to‑end ecosystem built to help organizations move beyond fragmented data and delayed insights toward greater confidence, consistency, and impact across the commercial lifecycle. For a concise look at how this comes together in practice, explore our latest fact sheet: https://lnkd.in/eDZfGhZ7
-